Work

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-170210

Authors: Brandon J Kale, Grace Hwang, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Institutions: Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310106489

FWCI: 0.179

Cites:

Cited by: 1

Related to: 10